AbbVie Earnings Miss Expectations: So What?

(MENAFN - Baystreet.ca) Markets responded too negatively to AbbVie (NYSE:ABBV) after the drug giant reported Q4 results that missed analyst estima.

Rheumatoid Arthritis Pathophysiology